STOCKSCOPE

Ansell (ASX: ANN) Holds FY27 Earnings Guidance as US Demand Strengthens. Can Margins Keep Rising?

Danny Aad

Danny Aad

Technology & Biotechnology Specialist | StockScope

Published:9 Nov 2026
Ansell (ASX: ANN) Holds FY27 Earnings Guidance as US Demand Strengthens. Can Margins Keep Rising?

Ansell Limited (ASX: ANN) has reaffirmed its FY27 earnings guidance following encouraging first-quarter trading, supported by resilient US demand and improving operating margins.

With earnings already growing faster than revenue, the protective equipment manufacturer faces an important test: can it sustain profitability improvements while managing elevated input costs, tariffs and uncertain economic conditions?

Its 9 November 2026 trading update suggests the recovery remains on track, although the unchanged guidance leaves little room for complacency.

Key Numbers

  • FY27 earnings guidance: Adjusted earnings per share (EPS) maintained at US158 cents to US170 cents, representing potential growth of 6.3% to 14.4% against FY26.
  • FY26 revenue: US$2.14 billion, up 6.8%, including 5.0% organic constant-currency growth.
  • Adjusted EBIT: US$321.9 million, up 14.1%, with operating margins improving to 15.0%.
  • Cash generation: US$270.1 million in adjusted operating cash flow during FY26, with net debt to adjusted EBITDA declining to 1.3 times.
  • Share price: A$45.66 at the 6 November close, representing approximately 26% growth over 12 months.

Latest Trading Update Reinforces Earnings Expectations

At its annual general meeting on 9 November, Ansell confirmed that first-quarter FY27 trading had progressed broadly in line with expectations.

Continued strength in its US operations supported good constant-currency sales growth, while supply chain productivity improvements and organisational changes contributed to positive earnings margin trends.

Management also reported that key input costs had retreated from their late-FY26 peaks, although they remained elevated.

Ansell continues to retain pricing flexibility to manage cost pressures, an important advantage given ongoing tariff uncertainty.

Despite these encouraging developments, management maintained its adjusted EPS guidance rather than upgrading expectations.

The update did not disclose quantified first-quarter revenue or margin figures, meaning the extent of the improvement remains difficult to assess independently.

What Stands Out: Earnings Are Outpacing Revenue

Ansell's FY26 performance demonstrated meaningful operating leverage.

Adjusted EBIT increased 14.1% against revenue growth of 6.8%, while the adjusted operating margin expanded 90 basis points to 15.0%.

The company's established brands, specialised protective products and global distribution network provide competitive advantages across healthcare, industrial safety and scientific markets.

US sales and global Cleanroom sales each increased 10% on an adjusted basis during FY26, highlighting demand in strategically important segments.

Cash generation also strengthened, supporting US$118.4 million in share buybacks and reducing net debt to approximately US$510.6 million.

However, valuation deserves attention.

At A$45.66 per share, Ansell carried a market capitalisation of approximately A$6.4 billion and traded at around 21 times trailing earnings.

That multiple suggests shareholders are already recognising improving profitability, increasing the importance of sustained earnings growth.

What Ansell Is Doing Now

Under chief executive Nathalie Ahlström, Ansell is pursuing commercial growth alongside operational simplification.

Its Accelerated Productivity Investment Program has achieved its US$50 million recurring pre-tax savings target, strengthening the company's cost base.

In October, Ansell completed its first upgraded commercial enterprise resource planning system implementation in North America, supporting efforts to improve operational efficiency.

The company is also prioritising higher-value protective products, specialised scientific applications and customer-focused initiatives.

These activities could support further margin expansion, although implementation costs and sustained market demand remain important considerations.

Insight: Can Ansell Justify Its Valuation Through Sustainable Growth?

We think Ansell's improving profitability, stronger cash generation and established market position provide credible foundations for continued earnings growth. Its specialised products, global scale and pricing flexibility offer meaningful competitive advantages. However, maintaining rather than upgrading FY27 guidance suggests management remains cautious about external pressures. With the shares trading at approximately 21 times trailing earnings, expectations already reflect considerable operational progress. Further margin expansion and consistent cash conversion would strengthen our positive assessment, while renewed cost pressures or weaker industrial demand could challenge the valuation.

What Happens Next?

Ansell's FY27 half-year results, scheduled for 22 February 2027, represent the next significant financial milestone.

The market will be watching US sales growth, adjusted operating margins, productivity benefits and cash conversion.

Continued demand for premium protective products, combined with easing input costs, could support further profitability improvements.

However, tariff uncertainty, weaker industrial activity and operational execution risks remain potential obstacles.

For shareholders, the critical question is whether Ansell can convert encouraging trading momentum into sustainable earnings and cash flow growth sufficient to support current market expectations.

Danny Aad

Danny Aad

(Technology & Biotechnology Specialist | StockScope)

Danny Aad is an experienced technology executive with a distinguished career spanning more than three decades, including senior leadership positions as Chief Technology Officer (CTO) across the technology and biotechnology sectors. With extensive expertise in technology strategy, digital innovation and the evolving biotechnology landscape, Danny brings a wealth of industry knowledge and technical insight to his analysis of emerging technologies, corporate developments and investment opportunities.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

Elsight (ASX: ELS) Secures Major US Defence Order. Could This Be the Start of Something Bigger?
Technology
Technology

Elsight (ASX: ELS) Secures Major US Defence Order. Could This Be the Start of Something Bigger?

A US defence manufacturer has increased its commitment to Elsight Limited ASX: ELS, placing its largest order yet with the Australian technology company. The approximately US$1 million purch...

Danny AadDanny Aad•
Immutep (ASX: IMM) Delivers Promising IMP761 Results. Could This Become Its Next Major Growth Driver?
Biotech & Health
Biotech & Health

Immutep (ASX: IMM) Delivers Promising IMP761 Results. Could This Become Its Next Major Growth Driver?

A potentially important breakthrough in immune suppression could strengthen the outlook for Immutep Limited ASX: IMM, following statistically significant clinical results for its experimenta...

Danny AadDanny Aad•
Northern Star Resources (ASX: NST) Faces a $36 Billion Test as Gold Production Delays Continue
Mining
Mining

Northern Star Resources (ASX: NST) Faces a $36 Billion Test as Gold Production Delays Continue

Northern Star Resources Ltd ASX: NST is facing a critical test of its growth strategy after commissioning difficulties at its expanded Kalgoorlie Consolidated Gold Mines KCGM processing plan...

Mark ElzayedMark Elzayed•
Pursuit Minerals (ASX: PUR) Secures US$40 Million EcoPro Funding Proposal, but Can It Close the Bigger Financing Gap?
Mining
Mining

Pursuit Minerals (ASX: PUR) Secures US$40 Million EcoPro Funding Proposal, but Can It Close the Bigger Financing Gap?

A proposed US$40 million strategic funding package could move Pursuit Minerals Ltd ASX: PUR significantly closer to developing its Rio Grande Sur lithium project in Argentina. However, the i...

Alison ElzayedAlison Elzayed•
Dyno Nobel (ASX: DNL) Delivers Record $485 Million Explosives Earnings, but Can It Turn Growth Into Cash?
Industrials
Industrials

Dyno Nobel (ASX: DNL) Delivers Record $485 Million Explosives Earnings, but Can It Turn Growth Into Cash?

Dyno Nobel Limited ASX: DNL has delivered record explosives earnings of $485 million and forecast further growth in FY27, strengthening its position as a global explosives specialist. Howeve...

Alison ElzayedAlison Elzayed•
Electro Optic Systems (ASX: EOS) Secures $23 Million Defence Order. Could a Smaller Contract Unlock Bigger Opportunities?
Industrials
Industrials

Electro Optic Systems (ASX: EOS) Secures $23 Million Defence Order. Could a Smaller Contract Unlock Bigger Opportunities?

A US$16 million approximately A$23 million counter-drone defence contract has opened another Middle Eastern market for Electro Optic Systems Holdings Limited ASX: EOS. While the agreement is...

Alison ElzayedAlison Elzayed•
Loading more stories...